Vana Papaevangelou (Greece)
University General Hospital “ATTIKON”, Athens, Greece PaediatricsAuthor Of 10 Presentations
Neutropenia in CCMV – With and Without Treatment
Panel discussion
Closing remarks
Expert
Panel discussion with questions from the audience
COVID-19 and children: What does the science tell us?
Round-Up and Reminder about ECCI
Question & Answer Session
Welcome and Introduction
Welcome and introduction
Presenter of 10 Presentations
Panel discussion with questions from the audience
COVID-19 and children: What does the science tell us?
Round-Up and Reminder about ECCI
Question & Answer Session
Welcome and Introduction
Welcome and introduction
Neutropenia in CCMV – With and Without Treatment
Panel discussion
Closing remarks
Expert
Moderator of 3 Sessions
Session Description:
In this session, the faculty will provide an overview of the burden of disease in children and adolescents during the COVID-19 pandemic. They will explore the clinical trial and real-world data for BNT162b2 in children and adolescents, and discuss the benefits and risks of COVID-19 vaccination in these populations and what impact this has on the wider population.
Session Description:
The Neisseria symposium will provide an overview of MenB vaccination in infants and adolescents as well as novel, emerging vaccine strategies. Prof. Muhamed-Kheir Taha will cover real-world evidence for 4CMenB in infants and important factors in driving recommendations. Prof. Lee Harrison will discuss the evidence and rationale for adolescent vaccination programmes. Lastly, Dr. Rino Rappuoli will highlight new scientific innovations in the field of Neisseria disease prevention.
Facilitator Of
Session Description:
In this session, the faculty will provide an overview of the burden of disease in children and adolescents during the COVID-19 pandemic. They will explore the clinical trial and real-world data for BNT162b2 in children and adolescents, and discuss the benefits and risks of COVID-19 vaccination in these populations and what impact this has on the wider population.
Session Description:
The Neisseria symposium will provide an overview of MenB vaccination in infants and adolescents as well as novel, emerging vaccine strategies. Prof. Muhamed-Kheir Taha will cover real-world evidence for 4CMenB in infants and important factors in driving recommendations. Prof. Lee Harrison will discuss the evidence and rationale for adolescent vaccination programmes. Lastly, Dr. Rino Rappuoli will highlight new scientific innovations in the field of Neisseria disease prevention.